The two closely related eukaryotic AAA + proteins (ATPases associated with various cellular activities), RuvBL1 (RuvB-like 1) and RuvBL2, are essential components of large multi-protein complexes involved in diverse cellular processes. Although the molecular mechanisms of RuvBL1 and RuvBL2 function remain unknown, oligomerization is likely to be important for their function together or individually, and different oligomeric forms might underpin different functions. Several experimental approaches were used to investigate the molecular architecture of the RuvBL1-RuvBL2 complex and the role of the ATPaseinsert domain (domain II) for its assembly and stability. Analytical ultracentrifugation showed that RuvBL1 and RuvBL2 were mainly monomeric and each monomer co-existed with small proportions of dimers, trimers and hexamers. Adenine nucleotides induced hexamerization of RuvBL2, but not RuvBL1. In contrast, the RuvBL1-RuvBL2 complexes contained singleand double-hexamers together with smaller forms. The role of domain II in complex assembly was examined by sizeexclusion chromatography using deletion mutants of RuvBL1 and RuvBL2. Significantly, catalytically competent dodecameric RuvBL1-RuvBL2, complexes lacking domain II in one or both proteins could be assembled but the loss of domain II in RuvBL1 destabilized the dodecamer. The composition of the RuvBL1-RuvBL2 complex was analysed by MS. Several species of mixed RuvBL1/2 hexamers with different stoichiometries were seen in the spectra of the RuvBL1-RuvBL2 complex. A number of our results indicate that the architecture of the human RuvBL1-RuvBL2 complex does not fit the recent structural model of the yeast Rvb1-Rvb2 complex.
INTRODUCTION
RuvBL1 {RuvB-like 1, also known as TIP49 (TBP [TATA-boxbinding protein)-interacting protein 49] and pontin} and RuvBL2 (also known as TIP48 and reptin) are two highly conserved eukaryotic AAA + proteins (ATPases associated with various cellular activities) that are engaged in a number of functionally important protein-protein interaction networks in all eukaryotic organisms [1] [2] [3] . The nomenclature standardization following publication of the human genome adopted the 'RuvB-like' name due to their structural homology with the bacterial Hollidayjunction branch migration protein RuvB. Nevertheless, they are functionally distinct from RuvB [4] [5] [6] [7] and are implicated in several diverse cellular functions. RuvBL1 and RuvBL2 are individually essential in all eukaryotes [6, 8, 9] and are involved in transcriptional regulation and chromatin remodelling [10] [11] [12] , DNA repair [4, 13] , snoRNP (small nucleolar ribonucleoprotein) biochemistry [14, 15] , telomerase activity [16] and mitotic spindle assembly [17] [18] [19] . Several of the pathways employing RuvBL1 and RuvBL2 are directly involved in cancer development, including the β-catenin/Wnt signalling pathway and the cMyc oncogenic pathway [20, 21] . RuvBL1 and RuvBL2 are deregulated in several clinical cases of cancer, but the role of RuvBL1 and RuvBL2 activity is not well understood [21] .
RuvBL1 and RuvBL2 participate in large multi-subunit complexes that include proteins such as INO80 [12] , SRCAP {SNF2-related CBP [CREB (cAMP-response-element-binding protein)-binding protein] activator protein} [22] , URI1 [23] , C/D-box snoRNP complexes [15] and TIP60 [4] . RuvBL1 and RuvBL2 are often present together in a 6:1 molar ratio relative to other proteins in these complexes [12] suggesting that both function as hexamers. Interestingly, the abundance of RuvBL1 and RuvBL2 in eukaryotic cells relative to other components of these complexes is too low for them to be permanently associated with each complex [2] . This suggests a transient function in complex assembly rather then direct catalytic activity. Indeed, in Saccharomyces cerevisiae RuvBL1 (Rvb1) and RuvBL2 (Rvb2) are needed for the correct assembly of the Ino80 complex by recruiting Arp5 [24] . RuvBL1 and RuvBL2 are required for the restructuring of the C/D-box snoRNP complex [15] and the assembly of active telomerase complex [16] . RuvBL1 and RuvBL2 activities may not always involve co-operation between the two proteins and they may act independently and in opposing fashion [8, 25, 26] ; complexes containing one of the proteins without the other have been identified [27] and RuvBL2 shows distinct localization during mitosis [19] . To date, no specific mechanism of action has been attributed to RuvBL1 and RuvBL2.
The hexamer or double-hexamer structure is a typical feature of AAA + proteins and is necessary for catalytic function [28, 29] . The crystal structure of human RuvBL1 showed it had a classic AAA + hexameric ring with the ATP-binding sites at the subunit interfaces [7] . The three domains in RuvBL1 are two 'RuvB-like' domains, I and III, which form the core hexameric ATPase ring, and a third domain, domain II, which is not found in bacterial RuvB. Domain
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II is incorporated between the Walker A and B motifs within domain I [7, 30] . Interestingly, the nucleotide-binding pockets occupied by ADP were enclosed in the RuvBL1 hexamer crystal structure, suggesting that a restructuring event is needed for the release of hydrolysed ATP. The weak ATPase activity of RuvBL1 and RuvBL2 in vitro increased synergistically when the proteins formed a double-hexameric complex [4, 5] showing that this is the enzymatically active form. The human RuvBL1-RuvBL2 complex showed two tightly packed and structurally distinct hexameric rings by negative-staining electron microscopy [5] . A very different structure for the yeast Rvb1-Rvb2 complex was obtained by cryo-electron microscopy [31] . The yeast model placed the two hexameric rings in an extended head-to-head orientation, in which domain II formed the interface between the rings. Immunolabelling of the yeast double-hexamer complex argued against the presence of mixed hexamers [31] . However, a different electron microscopy study of yeast Rvb1-Rvb2 showed a mixed single hexameric complex [32] .
The discrepancies between the human and yeast structures suggest that RuvBL1 and RuvBL2 may form structurally distinct complexes. To investigate the different oligomeric forms of the human RuvBL1/2 proteins and the architecture of their complex we used SEC (size-exclusion chromatography), AUC (analytical ultracentrifugation) and MS. Using sedimentation velocity as a quantitative tool, we show that ligand-free RuvBL1 and RuvBL2 are individually monomeric and that RuvBL2 forms a hexamer in the presence of nucleotide. Molecular modelling of the AUC results revealed that RuvBL1-RuvBL2 complexes comprised monomeric, dimeric, trimeric, hexameric and dodecameric species; MS provided direct evidence that the complex contained mixed hexamers with various stoichiometries. In the present studies we also used mutants of RuvBL1 and RuvBL2 without the globular region of domain II. The deletion mutants could form double-hexamers, but the deletion of RuvBL1 domain II destabilized the double-hexamer. Mixed hexamers with different stoichiometries were also identified in the deletion mutants. In summary, we show that RuvBL1/2 exists in a series of oligomeric forms, whose assembly could be regulated by domain II. Our findings about the human RuvBL1-RuvBL2 complex cannot easily fit the structural model of the yeast Rvb1-Rvb2 complex.
EXPERIMENTAL Protein expression and purification
His 6 -RuvBL1 was expressed using the pET15-His 6 -RuvBL1 expression plasmid in BL21-Gold (DE3) Escherichia coli and purified by Talon ® metal-affinity (Clontech) and hydroxyapatite column chromatography [5] . RuvBL2-His 6 was expressed using the pET21-RuvBL2-His 6 expression plasmid in BL21-Gold (DE3) E. coli and purified using Talon ® metal-affinity and MonoQ column chromatography [5] . For co-expression of the (RuvBL1-His 6 )-RuvBL2 complex, a pET21-based plasmid encoding both RuvBL1-His 6 and RuvBL2 was transformed into BL21 Rosetta II (DE3) E. coli. After protein expression [5] , the soluble lysate was applied to a Talon ® metal-affinity column. RuvBL1-His 6 and RuvBL2 were both captured, and eluted at approx. 50-150 mM imidazole using a gradient from 0 to 250 mM. The proteins were dialysed into R buffer [20 mM Tris/HCl, pH 8, containing 100 mM NaCl, 1 mM PMSF, 1 mM dithiothreitol and 10 % (v/v) glycerol] supplemented with either 1 mM EDTA or 2 mM MgCl 2 . The sample was passed through a single-stranded-DNAcellulose column and the flow-through was concentrated to 0.5 ml using Amicon Ultra 10 kDa-exclusion centrifugal concentrators (Millipore), then further purified by SEC on a Superose TM 6 HR column.
Domain II-deletion mutant constructs and purification
pET15-His 6 -RuvBL1, pET21-RuvBL2-His 6 and pET21-based co-expression plasmids were generated from the wildtype constructs by a single-step PCR using the Phusion ® sitedirected mutagenesis kit (Finnzymes). Primers were designed so that residues Glu 126 -Ile 234 were removed to create RuvBL1 and residues Glu 133 -Val 238 were removed to create RuvBL2. Deletion of the entire domain II of RuvBL1, as defined by the crystal structure (residues 121-295), resulted in a totally insoluble protein as reported previously [7] . The missing residues were replaced with Ala-Gly-Ala in the resulting recombinant proteins.
SEC
Proteins were dialysed against R buffer with 1 mM EDTA or 2 mM MgCl 2 , and incubated for 20 min on ice with 1 mM ATP when required. The samples (up to 5 mg of protein in 500 μl) were filtered through 0.2-μm-pore syringe filters (Millipore), loaded on to a Superose TM 6 HR column and eluted in R buffer (with 1 mM EDTA, or 2 mM MgCl 2 with 0.1 mM ATP as required). Absorbance profiles were detected at 280 nm, and 1 ml fractions were collected and analysed by SDS/PAGE (12 % gels). Protein molecular masses were estimated by comparison with five standards (Bio-Rad) and Dextran Blue. Fraction 15 from the SEC purification of RuvBL1/2 was reapplied to the Superose TM 6 column in R buffer with no EDTA. Fractions 14-16 were incubated with 200 μl of Talon ® resin for 30 min at 4
• C with mild agitation. The resin was washed twice with Talon ® buffer and the protein was eluted for SDS/PAGE analysis by incubating the resin with 500 μl of Talon ® buffer supplemented with 200 mM imidazole for 10 min at 4
• C.
Reconstitution of RuvBL1-RuvBL2 complex
RuvBL1-His 6 and RuvBL2-His 6 (0.8 mg of each from the 70 kDa fraction) were mixed in 10 ml of R buffer containing 1 mM EDTA and incubated for 15 min on ice. To test the effect of ATP, 0.8 mg of RuvBL2-His 6 in R buffer was supplemented with 5 mM MgCl 2 and 1 mM ATP. Following incubation for 15 min on ice, 0.8 mg of RuvBL1-His 6 was added to a final volume of 10 ml. Both mixtures were concentrated to 0.5 ml and fractionated by SEC on a Superose TM 6 HR column.
AUC results and analyses
RuvBL1, RuvBL2 and the RuvBL1-RuvBL2 complex were dialysed extensively against one of four different AUC buffers supplemented with cofactors as required: (i) the EDTA buffer comprised 20 mM Tris/HCl, pH 8, 200 mM NaCl, 0.1 mM dithiothreitol and 0.1 mM EDTA; (ii) the magnesium buffer was 20 mM Tris/HCl, pH 8, 200 mM NaCl, 0.1 mM dithiothreitol and 2 mM MgCl 2 to which was added either; (iii) 0.5 mM ATP; or (iv) 0.5 mM ADP, when preparing the ATP and ADP buffers respectively. Buffer densities and viscosities of 1.0072 g/ml and 0.01027 cP (1 cP =1 mPa · s) for the four buffers were calculated from compositions using SEDNTERP [33] . ADP and ATP were added after sample dialysis. Protein concentrations were determined either from Bradford assays using BSA as a standard or from 280 nm molor absorption coefficients of 3.49 for RuvBL1, 3.64 for RuvBL2 and 3.57 for their complex [1 % (w/v), 1-cm path length] calculated from compositions [34] . Sedimentation velocity runs were performed using Beckman Optima XL-I analytical ultracentrifuges at 20
• C using an AnTi50 rotor. Absorbance and interference data sets were collected at rotor speeds of 25 000, 30 000, 35 000 and 42 000 rev./min for RuvBL1 and RuvBL2, and 25 000 and 30 000 rev./min for the RuvBL1-RuvBL2 complex in two sector cells with column heights of 12 mm. The different rotor speeds established the absence of rate exchange or rotor speed effects on the sedimentation coefficient (S 0 20,w ) analyses [35] . Scans were recorded at 8 min intervals until sedimentation was complete. Molecular masses and partial specific volumes of 52.4 kDa and 0.747 ml/g for RuvBL1, 52.1 kDa and 0.743 ml/g for RuvBL2, and 102.5 kDa and 0.745 ml/g for the RuvBL1-RuvBL2 complex were calculated from compositions [34] . Sedimentation analysis was performed using direct boundary Lamm fits from 70 to 110 absorbance or interference scans using SEDFIT (version 9.4b) [36] . SEDFIT resulted in size distribution c(s) analyses that assumed that all of the observed species have the same frictional ratio (f /f 0 ). The analysis of c(s) fitted for oligomeric species followed previous procedures [37] .
Hydrodynamic modelling of sedimentation coefficients
RuvBL1 and RuvBL2 oligomers were modelled using the crystal structure of the human RuvBL1-ADP complex (PDB code 2C9O) [7] . Hexamer 1 was generated from monomer A in spacegroup P 6, using the protein quaternary structure website at http://pqs.ebi.ac.uk/. Hexamer 1 showed that an accessible surface area of 4102 Å 3 (1 Å=0.1 nm), 15.8 % of the total, was lost on hexamer formation, and all six monomers were in the same symmetric orientation around the hexameric ring. Up to ten salt bridges between each monomer and its two neighbours occurred between Arg 14 The symmetry operators for the six monomers were defined by X, Y, Z; Y, -X+Y, Z; X-Y, X, Z; -X+Y, -X, Z; -Y, X-Y, Z; and -X, -Y, Z. Hexamer 2 was generated by alternating the orientation of monomers B and C around the ring. Monomer, dimer, trimer, hexamer, nonamer and dodecamer structures were created using INSIGHT II 98.0 molecular graphics software (Accelrys) on Silicon Graphics OCTANE workstations. The (S 0 20,w ) values were calculated directly from atomic coordinates using HYDROPRO with the default value of 0.31 nm for the atomic element radius to represent the hydration shell [38] . The agreements between experimental and predicted (S The electron microscopy structure for the RuvBL1-RuvBL2 complex at 20 Å resolution was downloaded from the threedimensional electron microscopy database (deposition code 1317; http://www.ebi.ac.uk/msd/projects/IIMS.html) [5] . This was converted into SPIDER format using EM2EM software (http://www.imagescience.de/em2em/). A pixel size of 3.3 Å and a density cut-off threshold of 0.547 generated a volume of 728 000 Å 3 , which was close to the sequence-derived volume of 751 000 Å 3 for the RuvBL1-RuvBL2 complex. The (S 0 20,w ) value was calculated using HYDROMIC [40] .
ATPase assays
Assays were carried out using the P i ColorLock TM ALS colorimetric kit (Innova Biosciences). Reactions were performed in a final volume of 200 μl in ATPase buffer (50 mM Tris/HCl, pH 8, 100 mM NaCl, 0.1 mg/ml BSA, 2 mM MgCl 2 and 0.5 mM ATP). To start the reactions, 20 μl of material from each fraction eluted from the Superose TM 6 column was added and the reactions were incubated at 37
• C for 30 min. After 30 min, 20 μl from each reaction was added to 5 μl of 0.5 M EDTA, pH 8.5, in 96-well round-bottomed tissue culture test plates (Techno Plastic Products) in triplicate. ALS Malachite Green (125 μl) was added to each well, the colour was then left to develop for 30 min and the absorbance at 635 nm was measured using a Tecan Sunrise microplate absorbance reader. Various concentrations of potassium phosphate (20 μl volume) were also measured as above, to generate a standard curve.
NanoESI (nanoflow electrospray ionization)-MS data and analyses
Proteins were buffer-exchanged into 250 mM ammonium acetate, pH 7.5, by SEC on a Superdex 200 10/300 gel-filtration column. SEC fractions were pooled and concentrated using Vivaspin 2-ml centrifugal concentrators with a molecular-mass-cut-off of 10 kDa (Sartorius) to a final concentration of approx. 20 μM.
MS measurements were carried out on a Synapt HDMS mass spectrometer (Waters). NanoESI of protein samples was performed using gold-coated glass capillaries prepared in-house. Typical conditions employed 2-3 μl of aqueous protein solution, capillary voltages of 1.1-1.5 kV, cone voltages of 50-80 V, and trap and transfer collision energies of 30 and 10 V respectively. For CID (collision-induced dissociation)-induced activation, the trap collision voltage was varied during the acquisition of spectra while keeping other settings constant. External calibration was achieved by using a 33 mg/ml aqueous solution of caesium iodide (Sigma-Aldrich).
RESULTS

Purification of RuvBL1, RuvBL2 and the RuvBL1-RuvBL2 complex
RuvBL1 and RuvBL2 were expressed in E. coli and purified. In agreement with our previous results, RuvBL1 was monomeric under all conditions tested by SEC, whereas RuvBL2 underwent adenine-nucleotide-dependent oligomerization [5] . This intrinsic difference between the two proteins could not be attributed to their His 6 tags for two reasons: first, identical elution profiles were observed with RuvBL1 tagged at the C-or N-terminus ( [5] , and the present study); and secondly, in the presence of 250 mM imidazole, RuvBL2-His 6 was still a mixture of hexamers and monomers similar to samples analysed in the absence of imidazole (results not shown).
RuvBL1-His 6 and untagged RuvBL2 were co-expressed in E. coli. The complex was captured on a metal-affinity column and further fractionated by SEC. A major species of approx. 617 kDa was eluted, in good agreement with the predicted molecular mass for a dodecamer of 622 kDa ( Figure 1A ), together with an excess of monomeric RuvBL1 at 55 kDa and a range of intermediate species. The two main fractions of the RuvBL1-RuvBL2 complex (fractions 13 and 14) were pooled and re-applied to the column at different dilutions ( Figure 1B) . At all concentrations, the complex eluted at exactly the same volume, which indicates that the dodecameric complex did not undergo concentration-dependent disassembly under these conditions. The effect of ATP on the RuvBL1-RuvBL2 complex was also examined. The peak fraction of the dodecamer was incubated with EDTA or with MgATP, then analysed by SEC. Upon incubation with MgATP, the dodecameric peak was still prominent but a new peak appeared ( Figure 1C ). This indicates partial dissociation of the dodecamer following incubation with ATP, but the species formed would be difficult to assess using SEC. Interestingly, RuvBL1 and RuvBL2 co-eluted down to fraction 15, which corresponds to a hexamer (Figures 1A). When reapplied to the column, fraction 15 still eluted as a hexamer ( Figures 1D and 1E ). Both RuvBL1-His 6 and the untagged RuvBL2 in the hexamer fractions could be captured on Talon ® resin ( Figure 1E , Talon lane), which shows the presence of a mixed RuvBL1-RuvBL2 oligomer, presumably a hexamer. A slight excess of RuvBL1 can be noted in the fractions, but a precise stoichiometry is difficult to derive due to the low protein concentration. The analysis of the RuvBL1-RuvBL2 complex by SEC revealed a heterogeneous population of oligomers but the predominant species in Figure 1(A) is the double-hexamer. It also displayed the highest ATPase activity (see below) and is therefore most likely to be the enzymatically active form of the complex.
AUC identifies several oligomers of RuvBL1 and RuvBL2 and their complex
The qualitative nature of SEC in observing effective hydrodynamic radii means that the number of subunits in the oligomers of RuvBL2 could not be accurately assigned. To elucidate further details on the assembly of the RuvBL1-RuvBL2 complex, AUC was performed. Sedimentation velocity data were collected for RuvBL1 and RuvBL2 in EDTA at concentrations between 0.1 and 2.0 mg/ml, and 0.1 and 1.5 mg/ml respectively at four rotor speeds. SEDFIT analyses of the interference optics data were used for all the scans to determine the size-distribution function c(s). For RuvBL1 in EDTA, the c(s) plots showed at least four discrete species reproducibly. The equivalent data sets from absorbance optics measured in the absence of nucleotides (which absorb strongly at 280 nm) were very similar (results not shown). The major peak was consistently observed at 2.9-3.1 S, and three additional peaks at 4.5-5.0 S, 6.5-7.0 S and 10.0-10.5 S were also observed that successively decreased in intensity (Figure 2A) . Importantly, the peak positions were unchanged with RuvBL1 concentration or with rotor speed (Figure 3 ), indicating that any exchange processes between the oligomers are slow on the time scale of sedimentation, in turn indicating that stable species have been observed. Assuming that the same frictional ratio f /f 0 of 1.36 + − 0.22 is applicable to all the peaks, the conversion of the c(s) curves into mass distribution c(M) curves showed that these species corresponded to monomer, dimer, trimer and hexamer forms respectively. Good agreement, within error, was obtained between each peak mass and the protein sequence mass (Table 1) . In agreement with previous SEC analyses [5] integrations of the c(s) peaks showed no significant change in their relative proportions when RuvBL1 was incubated with 0.5 mM ADP or ATP in the presence of 2 mM Mg 2+ ( Figure 2B ; ADP results not shown), even though the different peak widths and heights in Figures 2(A) and 2(B) may suggest otherwise.
The c(s) analyses of the interference optics data for RuvBL2 collected in 0.1 mM EDTA, revealed the same four peaks as for RuvBL1 ( Figure 2C ). The 2.9-3.1 S peak was again the principal species, and minor peaks were observed at 4.5-5.0 S, 6.5-7.0 S and 10.0-10.5 S (Table 1) . Again, no dependence of the peaks on concentration or rotor speed was observed (Figure 3) . These species were assigned as monomers, dimers, trimers and hexamers from the c(M) analyses (Table 1) . In marked distinction to RuvBL1, the pre-incubation of RuvBL2 with either 0.5 mM ADP or ATP in 2 mM MgCl 2 caused the hexamer peak at 10.0-10.5 S to become predominant, together with much reduced intensities of the monomer, dimer and trimer peaks ( Figures 2D;  ADP results not shown) . Thus both ADP and ATP in the presence (1, 2, 3, 6, 9 or 12) . These results are summarized in Table 1. of MgCl 2 induced RuvBL2 to form hexamers. We conclude that the 70 and 400 kDa species observed previously for RuvBL2 by SEC [5] corresponded to a mixture of monomer/dimers and hexamers respectively.
The RuvBL1-RuvBL2 complex was analysed by AUC using the high-molecular-mass fractions between 12.5 ml and 14.5 ml from SEC ( Figure 1A) . Velocity results using interference optics were collected at concentrations of 0.1-0.8 mg/ml. The c(s) analyses for the RuvBL1-RuvB2 complex in EDTA showed a series of oligomers ( Figure 2E) . No concentration or rotor speed dependence of the peaks was seen (Figure 3) . The 3.0-3.3 S peak was attributed to the monomer of either RuvBL1 or RuvBL2. Prominent peaks at 4.5-5.0 S, 6.5-7.0 S and 10.0-10.5 S were attributed to dimers, trimers and hexamers (Table 1) . A major new peak now appeared at approx. 18.3 S, which corresponded to a larger RuvBL1-RuvBL2 complex ( Figure 2E ). An intermediate peak between the 10.3 and 18.3 S peaks was difficult to measure accurately due to poor resolution. As the pre-formed RuvBL1-RuvBL2 complex had been isolated using SEC, the observation of the separate species indicates that there was a partial dissociation of the complex during ultracentrifugation. As with the SEC experiments ( Figure 1C) , the presence of 0.5 mM ADP or ATP in 2 mM MgCl 2 notably increased the relative proportion of the hexamer at 10.3 S, although the 18.3 S peak was still prominent ( Figure 4F ). This outcome can be attributed to dissociation of the dodecamer into hexamers. Hexamer formation from free RuvBL2 in the presence of ADP or ATP could also contribute to this peak, but the level of free RuvBL2 in the starting material would be too low to explain the effect observed ( Figure 2D ).
For the RuvBL1-RuvBL2 complex, the c(M) plots showed molecular masses that were 30-70 % higher than expected (Table 1 ). This increase was attributed to a 30 % increase in the fitted frictional ratio f /f 0 , to 1.76 + − 0.23 for the RuvBL1-RuvBL2 complexes, compared with the individual proteins. This change may reflect the more complicated shapes of the higher oligomers (see below). Accordingly, whereas the sedimentation values remained similar for RuvBL1, RuvBL2 and their complexes, the c(M) masses were not able to identify the oligomer stoichiometry for the complex.
Confirmation of sedimentation coefficients by modelling
Sedimentation coefficients were calculated from the RuvBL1 crystal structure [7] in order to confirm the c(s) analyses (Figure 4 ). Sequence and secondary structure comparisons indicated that the RuvBL1 and RuvBL2 structures were very similar. Thus RuvBL2 contained 463 residues, only 13 more than RuvBL1. Residue conservation is high at 42 % between the two sequences, especially in the secondary structural regions seen in the RuvBL1 crystal structure. Two alternative hexamers could be generated from the RuvBL1 crystal structure. Hexamer 1 corresponds to six copies of monomer A in the same orientation, whereas hexamer 2 corresponds to monomers B and C in alternating orientations (see the Experimental section). Hexamers 1 and 2 differ mainly in the location of the extended domain II region, which is most likely to result from different crystal packing. Hexamer 1 gave predicted sedimentation coefficients of 3.3 S, 5.2 S, 6.8 S and 10.6 S for the monomer, dimer, trimer and hexamer forms of RuvBL1 respectively. Hexamer 2 gave slightly higher predicted values. These agree well with the observed sedimentation values for RuvBL1 and RuvBL2 (Table 1) .
The sedimentation coefficient of the dodecamer was calculated from hexamer 1 and the electron microscopy reconstruction of the RuvBL1-RuvBL2 complex [5] . Hexamer 1 is most compactly arranged in a head-to-tail configuration (Figure 4 ). From this, the predicted sedimentation coefficient of 18.4 S agrees with the observed value of 18.4 S. Such a head-to-tail arrangement would account for the existence of even higher oligomers, such as an 18-mer, and would account for additional features seen in Figure 1 (A) at high mass and in Figures 2(E) and 2(F) at high sedimentation coefficients. The electron microscopy model gave a predicted sedimentation coefficient of 19.0 S, also in good agreement with the experiment. Thus we conclude that the
Figure 4 Oligomeric forms of RuvBL1 used for modelling predictions of the sedimentation coefficients
The predicted sedimentation coefficient from each model is shown in parentheses. In the top row, side views show the monomers in the dimer and trimer as orange, blue and green ribbon traces. The electron microscopy map of the RuvBL1-RuvBL2 complex is superimposed on to the dodecamer head-to-tail model. In the middle row, the side view of the hexamer is shown in magenta with the six bound ADP molecules in blue. The addition of trimers to form either the nonamer or dodecamer has the same colours in the top row. In the bottom row, the hexamer and electron microscopy models are rotated by 90 o to reveal the void at the middle of the hexamer.
sedimentation coefficient for the dodecamer is explained well by the modelling.
Domain II-deletion mutants RuvBL1 and RuvBL2 form double-hexameric complexes
The above modelling results are consistent with a head-to-tail configuration of the double-hexameric complex but cannot prove this model. In the head-to-head model proposed [31] the interface between the two hexamers involves interactions between domain II. To assess the importance of domain II for the RuvBL1-RuvBL2 complex, mutants lacking domain II ( ) were engineered. Soluble proteins were generated when the deletions made retained the part of domain II considered to be necessary for domain I to fold correctly, and were 12 kDa smaller than the full-length protein.
Residues Glu 126 -Ile 234 (α-carbon separation of 5.3 Å) for RuvBL1-His 6 , and Glu 133 -Val 238 for His 6 -RuvBL2 were replaced with a flexible Ala-Gly-Ala linker. These residues occur at the centre of the two long β-strands that connected the bulk of domain II to domain I ( Figure 5) .
The deletion mutants of RuvBL1 and RuvBL2 were analysed individually by SEC. Similar to the wild-type protein, RuvBL1 eluted as a monomer of 40 kDa and was not affected by MgATP (results not shown). In EDTA RuvBL2 eluted as a monomer, at 45 kDa, a probable hexamer, at 220 kDa, and a range of higher-molecular-mass species. Unlike the full-length RuvBL2, incubation of RuvBL2 with MgATP had no effect on the elution profile ( Figure 5A ) but concentration-dependent changes in the RuvBL2 oligomers were observed ( Figure 5B ). These observations implicate the globular region of domain II of RuvBL2 in regulating the nucleotide-dependent oligomerization of RuvBL2.
Three different RuvBL1-RuvB2 complexes containing one or both of the deletion mutants were examined. The complexes of RuvBL1-RuvBL2, RuvBL1-RuvBL2 and RuvBL1-RuvBL2 were captured on a Talon ® column, fractionated by SEC and then ATPase activity was measured across the eluted fractions. As a benchmark, the full-length RuvBL1-RuvBL2 complex eluted predominantly as a double-hexamer at approx. 617 kDa, and these complexes displayed the highest ATPase activity; the free RuvBL1 monomer had little activity ( Figures 6A  and 6C ). The elution profiles of the mutant complexes each contained a prominent dodecamer peak ( Figures 6D, 6G and 6J). The calculated molecular masses were all consistent with the expected values of a double-hexamer. In sedimentation velocity experiments, the c(s) plots for RuvBL1-RuvBL2 and RuvBL1-RuvBL2 displayed both hexamer and doublehexamer peaks (results not shown). These results demonstrate that the globular region of domain II is not essential for doublehexamer formation. Moreover, the peak ATPase activity was consistently observed in the fractions corresponding to doublehexamers ( Figures 6F, 6I and 6L) .
Although the deletion of domain II of RuvBL2 had no effect on the dodecameric complex, that of RuvBL1 clearly did. The RuvBL1-RuvBL2 complex was exclusively dodecameric and virtually identical to the full-length complex (compare Figures 6G  and 6A ). This shows that the globular region of RuvBL2 domain II is not engaged in contacts between the two hexameric rings. However, the elution profiles of both RuvBL1-RuvBL2 and RuvBL1-RuvBL2 showed a clear second peak corresponding to a hexamer ( Figures 6D and 6J) . The appearance of hexamers indicates that, unlike RuvBL2, domain II of RuvBL1 contributes to stable contacts between the two rings in the double-hexamer.
Reconstitution of RuvBL1/2 complexes and effect of MgATP
The results presented above could not distinguish between RuvBL1-RuvBL2 complexes consisting of homo-or heterohexamers. We wanted to test whether nucleotide-induced hexamerization of RuvBL2 would act as a scaffold for RuvBL1 hexamerization, thereby facilitating the assembly of the RuvBL1-RuvBL2 complex comprising homohexamers. Complexes were assembled from purified RuvBL1 and RuvBL2 in EDTA or MgATP and analysed by SEC. The complex reconstituted in EDTA eluted with a peak at 13.4 ml, at the position of the double-hexamer (Figure 7 ). Both proteins co-eluted in the highmolecular-mass fractions along with some monomeric RuvBL1. Even though the protein levels were very similar in the starting mixture, a slight excess of RuvBL2 could be seen in these heavier fractions. The complex reconstituted in the presence of MgATP eluted with a peak at 14.1 ml, shifted towards the position of a hexamer, and the two proteins showed clear equimolar ratios in all oligomeric fractions ( Figure 7B ). The predominance of the hexamers in MgATP could be due to dissociation of the doublehexamers as seen by SEC and AUC (Figures 1 and 2) . It is worth noting that the reported yeast Rvb1-Rvb2 mixed hexamers were formed in the presence of different adenine nucleotides [32] . The reconstitution experiments in MgATP argue against a role for a preformed RuvBL2 hexameric ring acting as a scaffold for the formation of a second RuvBL1 hexamer. The results are consistent with the formation of mixed hexamers, in agreement with MS data (below). They also suggest that ATP binding and/or hydrolysis facilitate the interactions between RuvBL1 and RuvBL2 and could regulate the assembly of equimolar complexes.
MS of the RuvBL1-RuvBL2 and RuvBL1-RuvBL2 high-molecular-mass fraction reveals heterogenous populations of mixed hexamers
The composition of the hexamers in the RuvBL1-RuvBL2 complex could be probed directly using MS. All experimental and theoretical masses are summarized in Table 2 . The NanoESI MS spectrum of the RuvBL1-RuvBL2 complex was obtained after separation of the hexameric fraction by SEC on a Superdex 200 column ( Figure 8A) . A well-resolved charge state series was obtained centred on 8250 m/z. Prior to comparison with the experiment, theoretically calculated masses from the protein sequences were corrected for the presence of salt and solvent adducts [41] . The ion series has a measured mass of 313682 + − 40 Da, which is consistent with that expected for a 4:2 stoichiometry of RuvBL1/RuvBL2, suggesting that both RuvBL1 and RuvBL2 monomers are present in the hexamer. Interestingly a second smaller ion series was also visible in the spectrum centred on 8197 m/z (Figure 8A, asterisk) . This has a mass consistent with a 3:3 stoichiometry of RuvBL1/RuvBL2. The presence of a second ion series with a mass corresponding to an alternative stoichiometry of the RuvBL1-RuvBL2 hexamer indicates that heterogenous populations of RuvBL1-RuvBL2 complexes can form in solution. In order to confirm the stoichiometry assignment and determine if both RuvBL1 and RuvBL2 monomers are present in the hexameric species, we employed tandem MS; in this experiment the quadrupole mass analyser of the tandem MS instrument is used as a filter to isolate a single charge-state of the hexameric complex, which is then subjected to energetic collisions with argon atoms to affect fragmentation. Such experiments have demonstrated previously that protein complexes fragment via the unfolding and dissociation of a protein monomer in a charge asymmetric fashion. This produces highly charged monomeric protein ions at low m/z and charge-deficient fragments of the remaining complex at high m/z [42] [43] [44] [45] .
The tandem MS spectrum of the 39+ charge state of the proposed 4:2 RuvBL1-RuvBL2 complex produced three such related fragment ion families ( Figure 8B ). The two ion-series labelled (1) in the spectrum result from the fragmentation of the 39+ hexameric ion to produce highly charged RuvBL1 monomer ions centred on 2020 m/z and ions from a pentameric RuvBL1-RuvBL2 complex with a stoichiometry of 3:2. Similarly, the peak series marked (2) results from the fragmentation of the 39+ charge state of the 4:2 hexamer to produce highly charged RuvBL2 monomer ions centred on 2040 m/z and ions from a pentameric RuvBL1-RuvBL2 complex with a stoichiometry of 4:1. The final ion series labelled (3) represents the loss of a 9 kDa fragment from one of the RuvBL proteins. This could have arisen from protease activity on the assembled complex, but due to an absence of a 9 kDa band in SDS/PAGE gels, it is believed that this fragment may have arisen from covalent fragmentation of an N-terminal portion of RuVBL1 at position 95 (cysteine-proline residues) in competition with non-covalent dissociation. This behaviour has been observed previously, in high-energy collisions of non-covalent complexes in surface-induced dissociation, and is particularly favoured at proline residues [46] . Similar experiments were performed on the hexameric fraction of the RuvBL1-RuvBL2 complex ( Figure 8C ). Again a wellresolved ion series was obtained. The predominant ion series is centred on 7115 m/z and also has a mass consistent with a 4:2 stoichiometry of RuvBL1/ RuvBL2. In this case a total of three ion series are distinguishable and are visible in the expansion of the spectrum [ Figure 3C , inset, labelled (a-c)] on the 35+ charge state and are consistent with 3:3, 4:2 and 5:1 stoichiometries of RuvBL1 to RuvBL2 respectively. Tandem MS experiments of the RuvBL1/ RuvBL2 complex also confirmed the presence of both proteins in the hexameric complex. The simultaneous presence of mixed hexamers with different stoichiometries in both the full-length and the deletion complexes may explain the difficulties in crystallizing these complexes.
The 4:2 stoichiometry of the hexamers observed was surprising, but was consistent with the slight excess of RuvBL1 over RuvBL2 observed in some of the preparations (e.g. Figures 1E and 7A ). It may be that the stoichiometry of the two proteins varied from one preparation to the next, which could be due to differences in expression levels of the two proteins. Nevertheless, it is clear that hexamers with different stoichiometries can form and are capable of hydrolysing ATP (Figure 6 ). The MS data clearly show that the hexamers that were analysed were mixed, but the mass and stoichiometry of the hexameric fraction does not provide evidence for a hexameric ring arrangement of the monomers. However, the modelling of the AUC data argues in favour of hexameric rings.
DISCUSSION
Cellular complexes that contain and depend on RuvBL1 and RuvBL2 are remarkably diverse. Understanding the intrinsic oligomerization properties of the proteins and their ability to selfassemble would provide the basis for future studies on their functional forms in the cell and the regulation of their function. AUC velocity results for RuvBL1, RuvBL2 and their complex, and the modelling of sedimentation coefficients, provided quantitative evidence for the subunit composition of their oligomers. Although monomers were predominant in the absence of cofactors, each of RuvBL1 and RuvBL2 also formed stable dimers, trimers and hexamers as minor species. Both AUC and SEC showed that RuvBL2 hexamers were formed in the presence of adenine nucleotides and Mg 2+ , whereas RuvBL1 remained unchanged. The RuvBL1-RuvBL2 complex showed a complex profile with a predominant double-hexamer. The AUC results suggest that the assembly pathway to the dodecamer involves monomers, dimers, trimers and hexamers as intermediates. As tetramers and pentamers are not seen, this indicates that hexamers are formed by a sequential mechanism based on the addition of monomer subunits. The monomer, dimer and trimer forms co-exist as stable species, whereas the formation of tetramers or pentamers appears to be kinetically less stable and will quickly progress to the hexamer. The observation of intermediate oligomers between monomer and dodecamer by AUC and SEC is of interest because of the absence of rapid exchange between these forms. This could be due to the heterogeneity of the complexes formed (see below). Slow interconversion between oligomers could also indicate the need for an activation mechanism to promote these exchanges. For RuvBL2, this is provided by ADP or ATP, and for both proteins, this is provided by forming the double-hexameric complex. Although the modelling confirmed the RuvBL1 and RuvBL2 stoichiometries deduced from the c(s) fits, the modelling does not distinguish between two homohexamers or two heterohexamers forming the dodecamer. The similar sedimentation coefficients for the RuvBL1 and RuvBL2 oligomers (Table 1) indicate that the individual proteins have similar solution structures, and that these are maintained after the addition of nucleotide cofactors.
The presence of mixed RuvBL1/2 hexamers was first suggested by observations in SEC experiments (Figure 1 ). MS provided direct evidence that the complexes contain mixed hexamers (Figure 8 ). SEC was used to separate hexamers and dodecamers with appropriate buffer exchange. Despite the presence of a dodecamer peak in the SEC profile, double-hexamers were not seen by MS in the corresponding fractions. Instead, all fractions showed identical spectra for hexamers. It is suspected that the double-hexamers were unstable due to the high ionic strength of the buffer used. This indicates that the mixed hexamers that were characterized originate from the dodecameric complex. In all experiments consistent levels of ATPase activity were measured, demonstrating the enzymatic competence of the complexes. This suggests that the close similarity between the two proteins makes them structurally, as well as enzymatically, interchangeable in the complex. However, they are individually essential in all eukaryotes [6, 8, 9] and their inability to substitute for each other underlines other dimensions of their specialized functions in vivo.
The observation of mixed hexamers with different stoichiometries was unexpected ( Table 2 ). The biological significance of such complexes is not clear. Careful examination of the yeast INO80 complex showed a 6:6 Rvb1/Rvb2 ratio [12] , but the stoichiometry of other complexes has not been determined. Given the variety of functions associated with RuvBL1 and RuvBL2 as a complex, as well as individually [8, 25, 26] , other structures may exist in vivo. The structural heterogeneity of the yeast complex has been noted and it was suggested that "double and single hexameric rings and even homo-and heterooligomers could represent different functional states of these proteins" [31] . The ability of RuvBL1 and RuvBL2 to form complexes with different compositions suggests that different complexes could form in vivo and perform different functions. The composition of the complexes must be tightly controlled. The reconstitution experiments in the present study point to a role of ATP in modulating the assembly of mixed hexamers. This is one of several factors that could explain the different structures that were characterized, as discussed in [47] . Posttranslational co-regulation of RuvBL1 and RuvBL2 expression in cell cultures was recently observed [48] . This could be necessary for maintaining the assembly of complexes containing equimolar ratios of RuvBL1 and RuvBL2. It was also noted that depletion of one of the proteins depletes the other [16, 48, 49] and that overexpression of either RuvBL1 or RuvBL2 could not be achieved in HeLa cells [16] . These results suggest that the predominant form in the cells is an equimolar RuvBL1-RuvBL2 complex.
The dodecameric human RuvBL1-RuvBL2 complex studied by electron microscopy was assembled from purified RuvBL2-His 6 and partially purified untagged RuvBL1 [5] . In the electron microscopy reconstruction major structural differences between the top and bottoms rings were observed and the simplest explanation proposed was a model of two homomeric rings in the complex [5] . However, in view of the MS data showing mixed hexamers, the structural differences between the two rings are more likely due to conformational differences. Equimolar amounts of the two proteins were observed in the dodecameric fraction [5] , consistent with a 3:3 stoichiometry in the rings, although heterogeneity of the samples could not be excluded.
The three-dimensional reconstructions of the human [5] and yeast [31] RuvBL1-RuvBL2 complexes are significantly different. In the yeast head-to-head model, the two hexamers interact via domain II contacts. The human complex is best represented by a stacked head-to-tail configuration of the two hexameric rings. Although a tail-to-tail configuration is also possible, a head-to-head arrangement could not be fitted (P. Wendler, unpublished work). This may reflect genuine differences between the yeast and human proteins. However, it seems more likely that different complexes may have been assembled and examined. Our results show that the removal of most of domain II still allowed the assembly of dodecameric complexes, accompanied with a synergistic increase in ATPase activity. A recent crystallographic report of the human RuvBL1-RuvBL2 complex using proteins that both lack the globular region of domain II, also showed a double hexamer [50] . The RuvBL1-RuvBL2 dodecamer clearly argues against a model in which the two hexamers interact primarily via domain II. However, the deletion of domain II of RuvBL1 destabilized the dodecamer indicating that some interactions between the hexameric rings involve the globular part of domain II of RuvBL1. Domain II of RuvBL2 had no effect on the formation of the dodecamer, but our observations indicate that the nucleotidedependent hexamerization of RuvBL2 is regulated by domain II. Conformational changes of domain II may be important for the mechanism of action of RuvBL1-RuvBL2 and their interactions with other proteins. The globular region of domain II is connected to domain I by two extended β-strands that may allow movement [7] . Such movement of domain II during the ATP-hydrolysis cycle is supported by conformational changes within the complex seen in the two yeast electron microscopy studies [31, 32] . Domain II movements upon ATP hydrolysis may explain how the RuvBL1 and RuvBL2 proteins are able to restructure protein complexes and modulate protein-protein interactions, such as in the telomerase complex [16] , microtubule dynamics [17] or snoRNP maturation [51] .
Different structural forms of the RuvBL1-RuvBL2 complex could underpin its functional diversity and may reflect the acquisition of novel functions in the evolution between yeast and mammals. For example, interactions with c-Myc in higher eukaryotes were mapped to RuvBL1 domain II [4] . The zebrafish liebeskummer mutation in RuvBL2 (reptin), which confers a phenotype of heart hyperplasia [26] , is caused by an insertion of three amino acid residues into domain II of RuvBL2 [26] . Factors associated with protein localization, such as nucleotides, interacting partners, post-translational modification, [52] could regulate the assembly of different complexes through domain II. Indeed, this may explain how RuvBL1 and RuvBL2 participate in different complexes that antagonistically regulate Wnt-dependent transcription [8, 25, 26] while they are both essential components of TIP60 [53] and INO80 [13] . RuvBL1-RuvBL2 complexes isolated from eukaryotic cells will have to be analysed to resolve the existing controversies, and higher resolution structures need to be obtained to understand the versatility and function of RuvBL1 and RuvBL2 in multicomponent biological complexes.
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